People: Eli Lilly and Co (LLY.N)

LLY.N on New York Stock Exchange

64.37USD
4:05pm EDT
Price Change (% chg)

$0.12 (+0.19%)
Prev Close
$64.25
Open
$64.10
Day's High
$65.65
Day's Low
$63.83
Volume
1,165,218
Avg. Vol
1,210,052
52-wk High
$65.65
52-wk Low
$47.53

Search Stocks

Ricks, David 

Brief Biography

Mr. David A. Ricks is Senior Vice President, President - Lilly Bio-Medicines of Eli Lilly and Co. He formerly was general manager of Lilly affiliates in China and Canada. Ricks' responsibilities will include the U.S., Japan, and Europe. Bio-Medicines encompasses the therapeutic areas of neuroscience, cardiovascular, autoimmunity, musculoskeletal, and urology. He is a 15-year Lilly veteran, has led three of Lilly's important affiliates: the U.S., China, and Canada. As president of Lilly USA since 2009, Ricks spearheaded a new operating model focused on customer satisfaction and revenue growth while preparing for patent losses and changes to the health care system in the United States. He joined Lilly in 1996 as a business development associate and held several management roles in U.S. marketing and sales before moving into key international roles for seven years - as president and general manager of Lilly's affiliate in China, one of the world's fastest-growing pharmaceutical markets. He previously served as general manager of Lilly Canada after roles there as director of pharmaceutical marketing and national sales director. He earned a bachelor's degree in business from Purdue University and an MBA from Indiana University. Prior to joining Lilly, he held positions with Hewlett-Packard Corp. and IBM.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

John Lechleiter

11,217,000

Derica Rice

5,176,820

Maria Crowe

--

Jan Lundberg

4,774,540

Melissa Barnes

--

Michael Harrington

3,174,220
As Of 30 Dec 2013
Search Stocks